Cardio Pharm Flashcards

1
Q

Where do dihydropyridine calcium channel blockers act?

A

On vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where do non-dihydropyridine calcium channel blockers act?

A

On heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nimodipine use

A

Subarachnoid hemorrhage (prevents cerebral vasospasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dihydropyridine clinical uses

A

HTN, angina, Raynaud phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drugs used in hypertensive urgency or emergency

A

Nicardipine, Clevidipine, Fenoldopam, Labetalol, or Notroprusside

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-dihydropyridine clinical uses

A

HTN, angina, atrial fibrillation/flutter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adverse effects of non-dihydropyridines

A

Cardiac depression, AV block, hyperprolactinemia, constipation, gingival hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adverse effects of dihydropyridines

A

Peripheral edema, flushing, dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of Hydralazine

A

Increase cGMP leading to smooth muscle relaxation. Vasodilates arterioles > veins; afterload reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical uses of hydralazine

A

Severe HTN, HF,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nitroprusside MOA

A

Increase cGMP via direct release of NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA for Fenoldopam

A

Dopamine D1 receptor agonist - causes coronary, peripheral, renal, and splanchnic vasodilation. Decreases BP and increases natriuresis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the adverse effects of nitrates?

A

Reflex tachycardia, hypotension, flushing, headache, “Monday disease”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When are nitrates contraindicated?

A

In right ventricular infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA for Ranolazine

A

Inhibits the late phase of sodium current thereby reducing diastolic wall tension and oxygen consumption. Does not affect HR or contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical use of Ranolazine

A

Angina refractory to other medical therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Adverse effects of Ranolazine

A

Constipation, dizziness, headache, nausea, QT prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA of Milrinone

A

Selective PDE-3 inhibitor.
In cardiomyocytes: Increase cAMP accumulation, leading to increase calcium influx, and increased inotropy and chronotropy.
In vascular smooth muscle: Increase cAMP accumulation, inhibition of MLCK activity, and general vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adverse effects of Milrinone

A

Arrhythmias, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name the HMG-CoA reductase inhibitors

A

Lovastatin, Pravastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA of Lovastatin, Pravastatin

A

Inhibit conversion of HMG-CoA to mevalonate, a cholesterol precursor; decrease mortality in CAD patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Adverse effects of HMG-CoA reductase inhibitors

A

Hepatotoxicity (increase LFTs), myopathy (when used with fibrates or niacin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Name the bile acid resins

A

Cholestyramine, colestipol, colesevelam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

MOA for bile acid resins

A

Prevent intestinal reabsorption of bile acids; liver must use cholesterol to make more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
MOA of Ezetimibe
Prevent cholesterol absorption at small intestine brush border
26
MOA of Fibrates
Upregulate LPL leading to increased triglyceride clearance. Activates PPAR-alpha to induce HDL synthesis.
27
Adverse effects of fibrates
Myopathy (increased risk with statins), cholesterol gallstones (via inhibition of cholesterol 7alpha-hydroxlase)
28
MOA of Niacin
Inhibits lipolysis (hormone sensitive lipase) in adipose tissue; reduces hepatic VLDL synthesis
29
Adverse effects of Niacin
Red, flushed face; hyperglycemia, hyperuricemia
30
Name the PCSK9 inhibitors
Alirocumab, evolocumab
31
MOA of PCSK9 inhibitors
Inactivation of LDL-receptor degradation, increasing amount of LDL removed from bloodstream
32
Adverse effects of PCSK9 inhibitors
Myalgias, delirium, dementia, other neurocognitive effects
33
MOA of Digoxin
Direct inhibition of Na+/K+ ATPase, leading to indirect inhibition of Na+/Ca2+ exchanger. Increased Ca2+ leads to positive inotropy. Also stimulates the vagus nerve leading to decreased HR.
34
Clinical uses of Digoxin
HF (increase contractility); atrial fibrillation (decrease conduction at AV node and depression of SA node)
35
Adverse effects of Digoxin
Cholinergic, hyperkalemia
36
Antidote for Digoxin
Slowly normalize K+, cardiac pacer, anti-digoxin Fab fragments, Mg2+
37
Quinidine, Procainamide, Disopyramide are in which class of drugs?
Class 1A Antiarrhythmics
38
MOA of class 1A antiarrhythmics
Increase AP duration, increase effective refractory period, increase QT interval, some potassium channel blocking effects
39
Adverse effects of class 1A antiarrhythmics?
Cinchonism, reversible SLE-like syndrome, HF, thrombocytopenia, torsades de pointes
40
Lidocaine, Mexiletine are in which class of drugs?
Class 1B Antiarrhythmics
41
MOA of class 1B antiarrhythmics
Decrease AP duration. Preferentially affect ischemic or depolarized Purkinje and ventricular tissue
42
Flecainide, Propafenone are in which class of drugs?
Class 1C Antiarrhythmics
43
MOA of class 1C antiarrythmics
Prolongs ERP in AV node and accessory bypass tracts
44
Adverse effects of class 1C antiarrhythmics
Pro-arrythmic, especially post MI
45
What kind of drugs are class II antiarrhythmics?
Beta blockers
46
MOA of class II antiarrythmics
Decrease SA and AV nodal activity by decreasing cAMP and Ca2+ currents. Suppress abnormal pacemakers by decreasing the slope of phase 4. Increase PR interval.
47
How is beta blocker overdose treated?
With saline, atropine, glucagon
48
What kind of drugs are class III antiarrhythmics?
Potassium channel blockers
49
Amiodarone, Ibutilide, Dofetilide, Sotalol
Class III antiarrhythmics
50
MOA of class III antiarrythmics
Increase AP duration, increase ERP, increase QT interval
51
What is an adverse affect of class III antiarrythmics
Torsades de pointes
52
Adverse effects of Amiodarone
Pulmonary fibrosis, hepatotoxicity, hypothyroidism or hyperthyroidism, acts as hapten, neurologic effects, constipation, cardiovascular effects
53
What type of drugs are class IV antiarrhythmics?
Calcium channel blockers
54
Verapamil, Diltiazem
Class IV antiarrhythmics
55
MOA of class IV antiarrhythmics
Decrease conduction velocity, increase ERP, increase PR interval
56
Adverse effects of class IV antiarrhythmics
Constipation, flushing, edema, cardiovascular effects
57
Adenosine MOA
Increase K+ out of cells leading to hyperpolarization of the cell and decreased Ca2+ influx, decreasing AV node conduction
58
Adverse effects of Adenosine
Flushing, hypotension, chest pain, sense of impending doom, bronchospasm
59
How are torsades de pointes and digoxin toxicity treated?
Mg2+
60
MOA of Ivabradine
Selective inhibition of funny sodium channels, prolonging slow depolarization phase (phase 4). Decreased SA node firing; negative chronotropic effect without inotropy. Reduces cardiac O2 requirement.
61
When is Ivabradine used?
Chronic stable angina in pts who can't take beta blockers. Chronic HF with reduced EF